GPC3-targeted CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GPC3-targeted CAR-T cell therapy, covering 2024-10-16 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies [Phase 1]